These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6355750)

  • 1. [Monitoring glucose tolerance and blood insulin in patients with chronic liver disease with a 5 year clinical history].
    Oehler G; Bleyl H; Matthes K
    Med Welt; 1983 Sep; 34(37):995-7. PubMed ID: 6355750
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on glucose tolerance, serum insulin and free fatty acid in chronic liver disease.
    Parida RK; Santhalia RR; Mishra PK; Pradhan N; Samal KC; Sahoo CS
    J Assoc Physicians India; 1981 Feb; 29(2):119-27. PubMed ID: 7021524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in blood sugar and blood insulin chronic liver diseases].
    Chiti E; Greco GM
    Minerva Med; 1982 Dec; 73(49-50):3495-8. PubMed ID: 6759984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma insulin, glucose and C-peptide responses to oral glucose tolerance test in patients with liver disease].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):657-61. PubMed ID: 6819876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum insulin levels and blood glucose after oral glucose loading in chronic liver patients with normal and with increased body weight].
    Oehler G; Bleyl H; Schmahl FW; Matthes K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1403-6. PubMed ID: 611854
    [No Abstract]   [Full Text] [Related]  

  • 6. The serum level of certain aminoacids in chronic liver diseases associated with impaired oral glucose tolerance.
    Sâmpelean D; Grigorescu M; Jebeleanu G; Vlad C
    Rom J Intern Med; 2006; 44(1):79-84. PubMed ID: 17236290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance and insulin resistance in patients with liver disease.
    Collins JR; Crofford OB
    Arch Intern Med; 1969 Aug; 124(2):142-8. PubMed ID: 5797072
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive insulin in schistosomal hepatic fibrosis.
    Nofal M; el-Sawy M
    J Trop Med Hyg; 1973 Jan; 76(1):16-8. PubMed ID: 4684162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of carbohydrate metabolism changes in children with diseases of the gastrointestinal tract and liver].
    Arsen'eva EN
    Vopr Okhr Materin Det; 1977; 22(2):20-2. PubMed ID: 841938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood sugar and blood insulin levels in duodenal peptic ulcer].
    Shvarts VIa; Saakian AG; Frolkov VK; Kuznetsov BG
    Klin Med (Mosk); 1982 Feb; 60(2):40-4. PubMed ID: 7040795
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma immuno-reactive insulin (IRI) and peripherel glucose utilization in bilharzial patients with impaired renal functions.
    El-Badry A; Hassaballah AM; El-Ayadi A; Barsoum RS; Shaheen MH; El-Ghoneimy EH; Abdel-Rahman Y; El-Bagoury I
    J Egypt Med Assoc; 1975; 58(7-8):361-9. PubMed ID: 1236509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.
    Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P
    Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between blood insulin response and blood potassium changes during oral glucose load (preliminary note)].
    Strollo G; Morè M; Di Pietro S; Di Cesare T; Peruzzi AM; Semprini A
    Boll Soc Ital Biol Sper; 1981 Oct; 57(20):2022-8. PubMed ID: 7032544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of phentolamine on the glucose metabolism in normal persons and patients with chronic kidney insufficiency].
    Spath P; Dittrich P; Sailer S; Sandhofer F
    Wien Z Inn Med; 1970; 51(9):437-45. PubMed ID: 4332691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.